All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

2019-12-12T12:36:23.000Z

Is the composition of gut fungal microbiota a predictor of mortality after allo-transplantation?

Bookmark this article

The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview with Florent Malard, Saint-Antoine Hospital, Paris, FR, was based on the question: Is the composition of gut fungal microbiota a predictor of mortality after allogeneic transplantation?

Dr Malard discusses the results of a study, presented during the ASH meeting, which found patients undergoing transplant had a low fungal microbiota diversity at day 0. This lack of diversity did not have an impact on outcome, unlike the bacteria microbiota. However, a high presence of Candida albicans at day 0 was associated with lower overall survival and GvHD-free disease-free survival. He concludes that moving forward, it will be important to consider how we integrate this new data into improvements in patient outcome.

Is the composition of gut fungal microbiota a predictor of mortality after allo-transplantation?

Your opinion matters

HCPs, what is your preferred format for educational content on the GvHD Hub?
8 votes - 26 days left ...

Newsletter

Subscribe to get the best content related to GvHD delivered to your inbox